Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

被引：1
|
作者：
Kow, Chia Siang [1 ]
Hasan, Syed Shahzad [2 ,3 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2021年 / 19卷 / 01期
关键词：
ANTIHYPERTENSIVE DRUGS; OUTCOME INCIDENCE; RISK; ANGIOEDEMA;
D O I：
10.1080/14779072.2021.1842050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [41] Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"
    Ferrario, Carlos M.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1401 - 1402
  • [42] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan, Norman M.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 582 - 583
  • [43] Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
    Khalili, Azadeh
    Karim, Hosein
    Bayat, Gholamreza
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (04) : 312 - 316
  • [44] The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Moretti, Myla E.
    Caprara, Daniela
    Drehuta, Irina
    Yeung, Emily
    Cheung, Stefanie
    Federico, Lisa
    Koren, Gideon
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2012, 2012
  • [45] The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Moretti, M. E.
    Caprara, D.
    Drehuta, I
    Yeung, E.
    Cheung, S.
    Federico, L.
    Koren, G.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2010, 88 (05) : 439 - 439
  • [46] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
  • [47] Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis
    Lo, Kevin Bryan
    Bhargav, Ruchika
    Salacup, Grace
    Pelayo, Jerald
    Albano, Jeri
    McCullough, Peter A.
    Rangaswami, Janani
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (12) : 919 - 930
  • [48] Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
    Zhou, Feng
    Liu, Ye-Mao
    Xie, Jing
    Li, Haomiao
    Lei, Fang
    Yang, Huilin
    Qin, Juan-Juan
    Cai, Jingjing
    Zhang, Xiao-Jing
    Wu, Bin
    Xia, Meng
    Xiang, Da
    Yang, Chengzhang
    Ma, Xinliang
    Xu, Qingbo
    Lu, Zhigang
    Lu, Haofeng
    Xia, Xigang
    Wang, Daihong
    Liao, Xiaofeng
    Peng, Gang
    Yang, Jun
    Huang, Xiaodong
    Zhang, Bing-Hong
    Yuan, Yufeng
    Wei, Xiang
    Liu, Peter P.
    Wang, Yibin
    Zhang, Peng
    She, Zhi-Gang
    Xia, Jiahong
    Li, Hongliang
    HYPERTENSION, 2020, 76 (02) : E15 - E17
  • [49] Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials
    Meza, Nicolas
    Perez-Bracchiglione, Javier
    Perez, Ignacio
    Carvajal, Cristhian
    Ortiz-Munoz, Luis
    Olguin, Pablo
    Rada, Gabriel
    Madrid, Eva
    MEDWAVE, 2021, 21 (02):
  • [50] Re: Association of Inpatient Use of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients with Hypertension Hospitalized with COVID-19
    Rouette, Julie
    Suissa, Karine
    Azoulay, Laurent
    EPIDEMIOLOGY, 2020, 31 (06) : E52 - E53
12345